GURU.Markets stock price, segment price, and overall market index valuation
The company's share price enVVeno Medical
enVVeno Medical is a company developing innovative valves for the treatment of venous insufficiency. Its stock price is a bet on the success of its unique technology. Its price is volatile and driven by news about clinical trials and regulatory decisions.
Share prices of companies in the market segment - Specialized medical equipment
enVVeno Medical is a medical company developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. We classified it as "Specialized Medical Equipment." The chart below shows how investors evaluate innovative solutions in vascular surgery.
Broad Market Index - GURU.Markets
enVVeno Medical is a medical company developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. As an innovator, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with enVVeno's performance to assess the state of this sector.
Change in the price of a company, segment, and market as a whole per day
NVNO - Daily change in the company's share price enVVeno Medical
The daily fluctuations of enVVeno Medical Corporation shares reflect the high volatility of the medical device sector. The indicator demonstrates sensitivity to news about clinical trials of its venous valves.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
enVVeno Medical Corporation is a company in the medical device sector. This chart illustrates the high volatility of the MedTech industry. Comparing it to NVNO, which focuses on treating venous diseases, helps assess the extent to which its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
enVVeno Medical is a company developing bioprosthetic valves for the treatment of venous insufficiency. Shares of this innovative medical technology company are responding to clinical successes and regulatory decisions, contributing to the overall volatility in the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization enVVeno Medical
enVVeno Medical Corporation's annual performance is the story of its unique venous valve development. Its 12-month market capitalization is entirely dependent on clinical trial data. Successful approval of its VenoValve® device could offer new hope for patients with chronic venous insufficiency, representing a breakthrough for the company.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
enVVeno Medical Corporation is a late-stage medical device company developing an innovative solution for the treatment of venous insufficiency. Its stock price is entirely dependent on clinical trial results and regulatory decisions. The chart reflects high risks and breakthrough potential.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
enVVeno Medical, which treats venous diseases, exemplifies the long journey of a medical startup. Its performance, compared to the market, reflects investors' faith in its technology during the clinical trials and regulatory approval stages. It's a story of a medical breakthrough, where each milestone can trigger explosive growth or decline.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization enVVeno Medical
enVVeno Medical is a late-stage medical device company. Its monthly performance is entirely dependent on the results of its key clinical trial and its interactions with the FDA. News of this process is the primary event shaping investor expectations.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
enVVeno Medical is developing an innovative venous valve for the treatment of chronic venous insufficiency. It is a non-surgical solution to this common problem. The graph below shows the overall dynamics in the specialized medical equipment sector, where breakthrough devices have the potential to change treatment standards.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Early-stage medical stocks are a venture bet on science. The chart below shows investors' overall risk appetite. Is enVVeno Medical moving at an extreme amplitude, amplifying market movements, as is typical for such stories?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization enVVeno Medical
enVVeno Medical, which develops non-surgical valves for the treatment of chronic venous insufficiency, is extremely sensitive to medical news. Its weekly stock price is a direct response to clinical trial data for its flagship product, VenoValve, and progress in obtaining regulatory approval.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
enVVeno Medical operates in the medical technology sector, where shared technological breakthroughs and regulatory decisions impact everyone. The success of one company can boost the entire segment. The chart shows whether the market perceives enVVeno as a promising player or simply part of the overall flow of venous disease treatment.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
As a biotech company, enVVeno Medical often ignores broader market trends. Its fate depends not on GDP or inflation, but on the results of clinical trials. The chart below clearly demonstrates how NVNO shares can rise or fall on their own news, while the overall market moves in a different direction.
Market capitalization of the company, segment and market as a whole
NVNO - Market capitalization of the company enVVeno Medical
The market capitalization of enVVeno Medical is a story of innovation in the treatment of venous insufficiency. The company develops bioprosthetic vein valves. Its market capitalization reflects how investors view this new technology and its potential to help millions of patients. It's a classic biotech story with high risk and reward.
NVNO - Share of the company's market capitalization enVVeno Medical within the market segment - Specialized medical equipment
enVVeno Medical is developing a technology to create new venous valves from a patient's own tissue to treat chronic venous insufficiency. Its market share in the medical device sector is based on this breakthrough approach. The graph shows the potential of its non-implantable solution in regenerative medicine.
Market capitalization of the market segment - Specialized medical equipment
enVVeno Medical is developing a technology to create new venous valves from a patient's own tissue to treat chronic venous insufficiency. The chart below shows the market capitalization of the specialized medical equipment sector. This is the valuation of this breakthrough regenerative technology.
Market capitalization of all companies included in a broad market index - GURU.Markets
enVVeno Medical develops bioprosthetic venous valves for the treatment of chronic venous insufficiency. Its market capitalization is a bet on a new approach to treating this condition. The chart below shows the economic weight of companies working in this field.
Book value capitalization of the company, segment and market as a whole
NVNO - Book value capitalization of the company enVVeno Medical
enVVeno Medical is based on a technology for treating venous insufficiency. The company's book value reflects its patents and inventory of the VenoValve® device—the first surgical valve for implantation in leg veins—and the capital for its clinical trials. The chart below shows how the company is building its capital base to bring this breakthrough product to market.
NVNO - Share of the company's book capitalization enVVeno Medical within the market segment - Specialized medical equipment
enVVeno Medical, a medical device developer, has key assets in the form of R&D centers and pilot production lines. The S_BCap_Seg chart shows its share of the innovative medical infrastructure.
Market segment balance sheet capitalization - Specialized medical equipment
enVVeno Medical develops bioprosthetic valves for the treatment of venous insufficiency. This is a knowledge-intensive business, requiring investment in both R&D and the production of complex medical devices. The chart below shows the balance between its intangible and tangible assets.
Book value of all companies included in the broad market index - GURU.Markets
enVVeno Medical's assets are focused on venous insufficiency treatment technology. The company's book value reflects its manufacturing capacity for the VenoValve, a surgically implantable bioprosthetic valve. This represents the company's core assets, aimed at solving a problem that affects millions of people.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - enVVeno Medical
enVVeno Medical develops bioprosthetic valves for the treatment of venous insufficiency. Its book value is low. Its market capitalization reflects its unique technology and the company's hopes that its product will become the first effective solution for millions of patients with this condition.
Market to book capitalization ratio in a market segment - Specialized medical equipment
enVVeno Medical develops technology to create venous valves for the treatment of chronic venous insufficiency. It is an innovative medical company. The chart shows how the market perceives its potential to solve this complex medical problem.
Market to book capitalization ratio for the market as a whole
enVVeno Medical develops a medical device for the treatment of venous insufficiency. The company's valuation is based on the potential of its technology. The chart shows how its market valuation reflects investor expectations for the approval and commercialization of this innovative medical device.
Debts of the company, segment and market as a whole
NVNO - Company debts enVVeno Medical
enVVeno Medical, a company developing medical devices for the treatment of venous insufficiency, is using debt to finance clinical trials. This chart shows the capital raised to test and obtain approval for its bioprosthetic venous valves. This represents an investment in breakthrough medical technology.
Market segment debts - Specialized medical equipment
enVVeno Medical is a company developing medical devices for the treatment of venous diseases, specifically vein valves. Currently in clinical trials, it relies entirely on external funding to continue its development. This chart shows its financial position and "margin of safety."
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio enVVeno Medical
enVVeno Medical develops medical devices for the treatment of venous insufficiency. This chart shows the extent to which the company relies on debt. For a medical company launching a new product, debt may be necessary for its commercialization, but this creates pressure on achieving sales volumes quickly.
Market segment debt to market segment book capitalization - Specialized medical equipment
enVVeno Medical develops innovative solutions for the treatment of venous diseases. This business requires significant investment in clinical trials. This chart for the specialized medical equipment sector shows how the industry as a whole funds innovation, allowing one to assess the risks and company strategy on the path to market.
Debt to book value of all companies in the market
enVVeno Medical is a company developing non-surgical treatments for venous insufficiency using bioprosthetic valves. This chart, which reflects the overall debt-to-book value ratio of the market, is important for understanding the investment climate in the medical device sector. The availability of capital determines enVVeno's ability to finance clinical trials.
P/E of the company, segment and market as a whole
P/E - enVVeno Medical
enVVeno Medical is developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. This graph reflects the potential for solving a serious medical problem. The high value of this indicator indicates expectations that their innovative device will help millions of patients and become a new standard of care, capturing a multi-billion dollar market.
P/E of the market segment - Specialized medical equipment
enVVeno Medical Corp. represents the medical device sector. This chart shows the average price-to-earnings ratio for this innovative industry. A company's price-to-earnings ratio (P/E) is higher than average, indicating that investors have high hopes for its venous valve and its potential to capture a multi-billion dollar market.
P/E of the market as a whole
enVVeno Medical is developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. It is an innovative solution for a common but difficult-to-treat condition. This chart shows sentiment in the medical device sector. The company's valuation depends on the success of its clinical trials and investor confidence that its product will become a standard of care.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company enVVeno Medical
enVVeno Medical develops bioprosthetic venous valves for the treatment of chronic venous insufficiency. The graph shows expected future revenue, which depends on the success of clinical trials and approval of this innovative medical implant.
%20P%2FE%20enVVeno%20Medical&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-enVVeno-Medical&v=1772702239866 "Chart of the company's future (projected) P/E enVVeno Medical")
Future (projected) P/E of the market segment - Specialized medical equipment
enVVeno Medical is developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. This chart shows how its future revenue expectations compare to the industry average. Does the market believe its technology will be the first effective solution for this common problem?
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772702239869 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
enVVeno Medical is developing an innovative device for the treatment of venous insufficiency. This medical technology is still in the development stage. The company's success depends on the results of clinical trials and regulatory approval. This is a story of medical innovation unrelated to general economic cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772702239874 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit enVVeno Medical
enVVeno Medical Corporation is a clinical-stage company developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. Its financial indicators currently reflect research and clinical trial expenses. This chart shows the investment volumes dedicated to bringing this innovative medical device to market.
Profit of companies in the market segment - Specialized medical equipment
enVVeno Medical Corporation is a clinical-stage company developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. This graph shows the profitability of its segment. This innovative solution could be the first of its kind. Research costs impact current overall profitability, but success could create an entirely new market.
Overall market profit
enVVeno Medical Corporation is developing and commercializing an innovative bioprosthetic device for the treatment of chronic venous insufficiency. The company's success depends on the results of clinical trials and recognition from the medical community. This chart illustrates the overall economic backdrop against which enVVeno is carving out its niche in the high-tech medical field.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company enVVeno Medical
enVVeno Medical is developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. This chart reflects analysts' expectations for future revenue, which are entirely dependent on the success of clinical trials and subsequent approval of this innovative medical device. It demonstrates the market's confidence in the company's potential.
%20profit%20of%20the%20company%20enVVeno%20Medical&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-enVVeno-Medical&v=1772702239892 "Graph of future (projected) profit of the company enVVeno Medical")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
enVVeno Medical Corporation is a late-stage medical technology company developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. This chart shows profitability forecasts for the specialized equipment sector. It reflects expectations for innovative solutions for the treatment of vascular diseases.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772702239901 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
enVVeno Medical develops venous valves for the treatment of chronic venous insufficiency. The introduction of new medical devices depends on funding and clinic budgets. The projected overall profit growth, reflected in the graph, creates a favorable economic environment for investment in the healthcare sector and accelerated innovation adoption.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772702239903 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - enVVeno Medical
enVVeno Medical develops medical devices for the treatment of venous insufficiency. During the commercialization stage, the P/S ratio becomes a key metric. It reflects how investors assess the acceptance of its innovative valve by surgeons and its potential for sales growth.
P/S market segment - Specialized medical equipment
enVVeno Medical is developing a non-surgical solution for the treatment of chronic venous insufficiency—a valve implanted through a catheter. This is a potentially breakthrough technology. This chart illustrates the high investor expectations for their innovative medical device and its future commercial potential in the large market.
P/S of the market as a whole
enVVeno Medical develops a medical device for the treatment of venous insufficiency. The company has no revenue, and its valuation is based on the potential of its technology. This chart, showing the valuation of companies with real revenue, emphasizes that enVVeno is betting on the future success of a single innovative medical product.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company enVVeno Medical
enVVeno Medical is developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. This is an innovative medical device. This chart reflects investor expectations for future revenue from sales of this implant, which depend on the success of clinical trials and its acceptance by vascular surgeons.
%20P%2FS%20enVVeno%20Medical&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-enVVeno-Medical&v=1772702239917 "The graph of the company's future (projected) P/S enVVeno Medical")
Future (projected) P/S of the market segment - Specialized medical equipment
enVVeno Medical Corporation is a late-stage medical technology company developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. This chart shows how the market perceives the future commercial potential of its unique device, comparing it to other specialized medical devices.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772702239918 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
enVVeno Medical is developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. It is an innovative solution for a common condition. This chart shows overall market revenue expectations, and NVNO demonstrates how medical technologies are striving to improve the quality of life for millions of patients.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772702239923 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales enVVeno Medical
enVVeno Medical Corporation is a clinical-stage medical technology company developing a novel surgical solution for the treatment of chronic venous insufficiency. Because its lead product has not yet received commercial approval, the company has no sales revenue, as reflected in this chart.
Sales of companies in the market segment - Specialized medical equipment
enVVeno Medical is a clinical-stage company developing bioprosthetic valves for the treatment of venous insufficiency. Currently, it has no product revenue. The graph may reflect revenue from grants or partnerships, which are the key source of funding for its development.
Overall market sales
enVVeno Medical Corporation develops medical devices for the treatment of venous insufficiency. The need for such procedures is determined by the patient's health status. This overall economic performance chart is not key for the company, as its success depends on the clinical effectiveness of its products and their acceptance by surgeons.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company enVVeno Medical
enVVeno Medical is developing a medical device to create new veins in patients with chronic venous insufficiency. Its revenue forecast depends on the success of clinical trials and the eventual approval of its technology. This chart reflects analysts' speculative expectations for its innovative solution.
%20sales%20of%20the%20company%20enVVeno%20Medical&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-enVVeno-Medical&v=1772702239941 "Schedule of future (projected) sales of the company enVVeno Medical")
Future (projected) sales of companies in the market segment - Specialized medical equipment
enVVeno Medical develops and commercializes surgical solutions for the treatment of venous insufficiency. This chart shows projected revenue for the entire specialized medical equipment segment. It reflects the demand for innovative treatments for chronic venous diseases, which is key to the commercialization of enVVeno's technology.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772702239944 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
enVVeno Medical is developing a medical device for the treatment of venous insufficiency. Its success depends on the results of clinical trials and regulatory approval. This graph of overall market expectations reflects the investment climate, which is important for funding capital-intensive R&D projects in the medical device sector.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772702239947 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality enVVeno Medical
enVVeno Medical is a medical company developing an innovative device for the treatment of venous insufficiency. This chart reflects the financial performance at the clinical trial stage. Future profitability is entirely dependent on the success and commercialization of its bioprosthetic venous valve.
Market segment marginality - Specialized medical equipment
enVVeno Medical Corporation is developing and commercializing a new surgical device, VenoValve, for the treatment of chronic venous insufficiency. This graph shows the average profitability in the specialized medical equipment sector. It allows one to estimate the market potential and profitability of this unique solution for patients with no other treatment options.
Market marginality as a whole
enVVeno Medical Corporation is developing a medical device for the treatment of venous insufficiency. This innovative product targets a large but underserved market. This gross profitability chart does not reflect the company's potential, which depends on successful clinical trials and the acceptance of the technology by the medical community.
Employees in the company, segment and market as a whole
Number of employees in the company enVVeno Medical
enVVeno Medical is a clinical-stage company developing an innovative solution for the treatment of venous insufficiency. Its small team consists of engineers and clinicians. This graph illustrates the size of the focused team advancing a single promising medical device through complex regulatory processes.
Share of the company's employees enVVeno Medical within the market segment - Specialized medical equipment
enVVeno Medical Corporation is a clinical-stage company developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. This chart illustrates its focus on an unsolved medical problem. It reflects the proportion of biomedical engineers and vascular surgeons working on this first-of-its-kind device that enVVeno brings together.
Number of employees in the market segment - Specialized medical equipment
enVVeno Medical Corporation develops a medical device for the treatment of chronic venous insufficiency. This chart shows the employment in the specialized medical equipment niche. The growing number of specialists in this field indicates the search for new, less invasive treatments for common vascular diseases.
Number of employees in the market as a whole
enVVeno Medical Corporation is a clinical-stage company developing bioprosthetic vein valves. Innovations in medical implants save and improve the lives of millions of people. This graph shows overall employment, and the medical technology sector is one of the most knowledge-intensive and fastest-growing in the modern economy.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company enVVeno Medical (NVNO)
enVVeno Medical is a medical device company. Its value lies in its intellectual property. This chart shows how the market values its patents and potential to transform medical practice. The high market capitalization per employee reflects investors' bet that their technology will become a new standard.
%20of%20the%20company%20enVVeno%20Medical%20(NVNO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-enVVeno-Medical-NVNO&v=1772702239981 "Chart of market capitalization per employee (in thousands of dollars) of the company enVVeno Medical (NVNO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
enVVeno Medical develops innovative valves for the treatment of venous insufficiency. In the medical device sector, the company's market capitalization per employee reflects the market's assessment of the potential of its unique technology. Its above-average performance indicates high expectations for the commercial success of its product.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772702239987 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
enVVeno Medical is a clinical-stage company developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. It is an innovative medical device. This chart shows how the market perceives the potential of a small team to solve a serious medical problem and create a new standard of care.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772702239996 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company enVVeno Medical (NVNO)
enVVeno Medical is a clinical-stage medical company developing a bioprosthetic valve (VenoValve) for the treatment of chronic venous insufficiency. This is an R&D business. This negative graph shows how much capital is burned for each employee leading this complex product through clinical trials.
%20Chart%20enVVeno%20Medical%20(NVNO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-enVVeno-Medical-NVNO&v=1772702240012 "Company Profit Per Employee (in thousands of dollars) Chart enVVeno Medical (NVNO)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
enVVeno Medical is a clinical-stage company developing a bioprosthetic venous valve for the treatment of chronic venous insufficiency. This graph illustrates the potential value of their medical device. It shows the high profit potential of a successful solution for a common medical problem, a measure of their innovative potential.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772702240020 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
enVVeno Medical (NVNO) is a company developing medical devices for the treatment of venous insufficiency, specifically the VenoValve bioprosthetic venous valve. It is an R&D business in the medical device sector. This chart shows the investment intensity per employee required to complete clinical trials and obtain FDA approval.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772702240030 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee enVVeno Medical (NVNO)
enVVeno Medical develops medical devices for the treatment of venous insufficiency. This graph shows the very beginning of the clinical trials and early implementation phase. Growth in revenue per employee will be a key indicator of acceptance of its technology by surgeons and an increase in the number of surgeries.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-enVVeno-Medical-NVNO&v=1772702240041 "Sales chart per company employee enVVeno Medical (NVNO)")
Sales per employee in the market segment - Specialized medical equipment
enVVeno Medical (NVNO) is a medical device company developing a venous valve (VenoValve) for the treatment of chronic venous insufficiency. This chart shows the average revenue per employee in the segment. For enVVeno, which is in clinical trials, comparing it to this benchmark (zero) underscores their focus on R&D.
Sales per employee for the market as a whole
enVVeno Medical (NVNO) is a clinical-stage medical technology company developing vein valves. Like other biotechs (PULM, CING), it has no revenue. Investors are focused on clinical data, which may or may not lead to approval and commercialization.
Short shares by company, segment and market as a whole
Shares shorted by company enVVeno Medical (NVNO)
enVVeno Medical (NVNO) is a medical company developing a valve (VenoValve) for the treatment of chronic venous insufficiency (CVI). This chart shows the odds on the failure of their device. "Bears" believe that clinical trials will fail to prove its safety and effectiveness, or that the implantation procedure will be too complex for widespread adoption.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-enVVeno-Medical-NVNO&v=1772702240056 "Short Shares Chart for the Company enVVeno Medical (NVNO)")
Shares shorted by market segment - Specialized medical equipment
enVVeno Medical (NVNO) is a medical technology company developing valves (VenoValve) for the treatment of venous insufficiency in the legs. This chart shows the pessimism in the sector. The growing short position in the industry is a bet that this implant won't take off. Investors fear that surgeons won't perform the risky procedure to treat varicose veins, or that insurers won't cover it.
Shares shorted by the overall market
enVVeno (NVNO) is an R&D company developing medical devices. It's a speculative bet. When this market fear indicator rises, investors' risk appetite plummets. They sell off unprofitable stocks like NVNO, whose fate depends on R&D and regulatory approval.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator enVVeno Medical (NVNO)
enVVeno Medical is developing an innovative valve (VenoValve) for the treatment of venous insufficiency. This is a highly specialized medical technology. This graph shows the FDA approval "pulse." The "temperature" of investor interest is "heating up" as the company approaches final phases of testing and potential market launch.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-enVVeno-Medical-NVNO&v=1772702240066 "RSI 14 indicator chart for the company's stock enVVeno Medical (NVNO)")
RSI 14 Market Segment - Specialized medical equipment
enVVeno Medical is a medical technology company developing the innovative VenoValve venous prosthesis for the treatment of severe chronic venous insufficiency (CVI) of the lower extremities. This chart measures the overall momentum in the specialized medical equipment sector and helps assess how the market views this industry.
RSI 14 for the overall market
enVVeno Medical (NVNO) is a biotech R&D company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NVNO (enVVeno Medical)
enVVeno Medical (NVNO) is a medical device company developing VenoValve, a first-of-its-kind implantable valve for the treatment of severe chronic venous insufficiency (CVI). This chart shows the average 12-month forecast, reflecting analysts' confidence in the success of this breakthrough device in clinical trials.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NVNO-enVVeno-Medical&v=1772702240075 "A chart showing analyst consensus forecasts for the expected stock price. NVNO (enVVeno Medical)")
The difference between the consensus estimate and the actual stock price NVNO (enVVeno Medical)
enVVeno Medical is a medical technology company developing a breakthrough valve (VenoValve) for the treatment of severe chronic venous insufficiency, a condition with no effective solutions. This chart shows how the current share price differs from the "fair" value predicted by analysts. It reflects their confidence in this important R&D program.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NVNO-enVVeno-Medical&v=1772702240078 "A chart showing the difference between the consensus forecast and the actual stock price. NVNO (enVVeno Medical)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
enVVeno Medical is a medical company developing a first-of-its-kind implantable "valve" (VenoValve) for the treatment of chronic venous insufficiency in the legs. This chart displays the general expectations of analysts for the specialized medical equipment sector. It shows whether experts believe this breakthrough, but risky, R&D bet will be successful.
Analysts' consensus forecast for the overall market share price
enVVeno Medical is a medical company developing an implantable valve (VenoValve) for the treatment of chronic venous insufficiency, a severe leg condition. This chart shows the overall "risk appetite" in the market. For enVVeno, a company with an innovative but risky surgical device, this overall optimism is crucial for funding long-term clinical trials.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index enVVeno Medical
enVVeno Medical is a MedTech company working on vein repair. Their signature product (VenoValve) is the world's first surgical implant (valve) designed to treat severe venous insufficiency (CVI) in the legs. This chart is a pure indicator of their R&D. It reflects their (very risky) path to FDA approval and the market's faith in their singular bet.
AKIMA Market Segment Index - Specialized medical equipment
enVVeno Medical (NVNO) is a medical device company developing VenoValve, the first surgical valve for on-the-go replacement, designed to treat chronic venous insufficiency (CVI) in the deep veins of the legs. The chart shows the average index for the segment, helping investors assess how this unique and vital technology compares to the average market.
The AKIM Index for the overall market
enVVeno Medical is a medtech company developing bioprosthetic venous valves (VenoValve) for the treatment of chronic venous insufficiency. This chart, reflecting the market average, provides context. It helps assess how this innovative approach, which addresses an unmet need, fits within the context of overall macroeconomic trends.
